143 results on '"Banks, Matthew L."'
Search Results
2. Environmental influence on the preclinical evaluation of substance use disorder therapeutics
3. Xylazine does not enhance fentanyl reinforcement in rats: a behavioral economic analysis
4. Effects of naltrexone on amphetamine choice in rhesus monkeys and rats.
5. Comparison of three DREADD agonists acting on Gq-DREADDs in the ventral tegmental area to alter locomotor activity in tyrosine hydroxylase:Cre male and female rats
6. Preclinical Models of Substance Use Disorder
7. Effects of selective dopamine D3 receptor partial agonist/antagonists on oxycodone self-administration and antinociception in monkeys
8. The Rise and Fall of Kappa-Opioid Receptors in Drug Abuse Research
9. A concurrently available negative reinforcer robustly decreases cocaine self-administration in male and female rats
10. Characterization of a Potential KOR/DOR Dual Agonist with No Apparent Abuse Liability via a Complementary Structure–Activity Relationship Study on Nalfurafine Analogues
11. Preclinical Characterization and Development on NAQ as a Mu Opioid Receptor Partial Agonist for Opioid Use Disorder Treatment
12. Effects of environmental manipulations on cocaine-vs-social choice in male and female rats
13. Effect of TRV130 and methadone on fentanyl-vs.-food choice and somatic withdrawal signs in opioid-dependent and post-opioid-dependent rats
14. Effects of environmental manipulations on cocaine-vs-social choice in male and female rats
15. Role of Efficacy as a Determinant of Locomotor Activation by Mu Opioid Receptor Ligands in Female and Male Mice
16. Logical fallacies and misinterpretations that hinder progress in translational addiction neuroscience
17. Lack of effect of the nociceptin opioid peptide agonist Ro 64-6198 on pain-depressed behavior and heroin choice in rats
18. Contextual extinction of drug‐associated discriminative stimuli fails to attenuate drug‐vs‐food choice in rhesus monkeys
19. Decoding the Structure of Abuse Potential for New Psychoactive Substances: Structure–Activity Relationships for Abuse-Related Effects of 4-Substituted Methcathinone Analogs
20. Pharmacokinetic–Pharmacodynamic (PKPD) Analysis with Drug Discrimination
21. Sex differences in the effect of chronic delivery of the buprenorphine analogue BU08028 on heroin relapse and choice in a rat model of opioid maintenance
22. Contributors
23. Nonhuman Primate Self-Administration in Assessments of Abuse Potential
24. Opioid Withdrawal Produces Sex-Specific Effects on Fentanyl-Versus-Food Choice and Mesolimbic Transcription
25. Adding dopamine to the complexity of sex differences in opioid reinforcement
26. Some effects of putative G-protein biased mu-opioid receptor agonists in male rhesus monkeys
27. A drug-vs-food “choice” self-administration procedure in rats to investigate pharmacological and environmental mechanisms of substance use disorders
28. Lack of effect of different pain-related manipulations on opioid self-administration, reinstatement of opioid seeking, and opioid choice in rats
29. Lack of effect of different pain-related manipulations on opioid self-administration, reinstatement of opioid seeking, and opioid choice in rats
30. Opioid withdrawal produces sex-specific effects on fentanyl-vs.-food choice and mesolimbic transcription
31. A synthetic opioid vaccine attenuates fentanyl-vs-food choice in male and female rhesus monkeys
32. Improving translation of animal models of addiction and relapse by reverse translation
33. Reviewers for Volume 2
34. Learning from lorcaserin: lessons from the negative clinical trial of lorcaserin to treat cocaine use disorder
35. Evaluation of a Dual Fentanyl/Heroin Vaccine on the Antinociceptive and Reinforcing Effects of a Fentanyl/Heroin Mixture in Male and Female Rats
36. Preclinical Evaluation of Vaccines to Treat Opioid Use Disorders: How Close are We to a Clinically Viable Therapeutic?
37. Pharmacological validation of a translational model of cocaine use disorder: Effects of d-amphetamine maintenance on choice between intravenous cocaine and a nondrug alternative in humans and rhesus monkeys.
38. Lorcaserin maintenance fails to attenuate heroin vs. food choice in rhesus monkeys
39. Effects of repeated kappa-opioid receptor agonist U-50488 treatment and subsequent termination on intracranial self-stimulation in male and female rats.
40. Medications Development for Treatment of Opioid Use Disorder
41. Effectiveness and selectivity of a heroin conjugate vaccine to attenuate heroin, 6-acetylmorphine, and morphine antinociception in rats: Comparison with naltrexone
42. Vaccine blunts fentanyl potency in male rhesus monkeys
43. Contextual extinction of drug-associated discriminative stimuli fails to attenuate drug-vs-food choice in rhesus monkeys
44. Lorcaserin maintenance fails to attenuate heroin vs. food choice in rhesus monkeys
45. Experimental design and analysis for consideration of sex as a biological variable
46. Sex differences in the effectiveness of buprenorphine to decrease rates of responding in rhesus monkeys
47. Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats.
48. Conjugate vaccine produces long-lasting attenuation of fentanyl vs. food choice and blocks expression of opioid withdrawal-induced increases in fentanyl choice in rats
49. Effectiveness comparisons of G-protein biased and unbiased mu opioid receptor ligands in warm water tail-withdrawal and drug discrimination in male and female rats
50. Effects of Dopamine D3 Receptor Compounds on Oxycodone Self‐Administration, Reinstatement and Antinociception in Monkeys
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.